Morelli D - Search Results

1

Segregation of type 1 cytokine production in human peripheral blood lymphocytes: phenotypic differences between IFN-gamma and IL-2-producing cells in the CD8+ T cell subset.

Caruso A, Licenziati S, Morelli D, Fiorentini S, Ricotta D, Malacarne F, Sfondrini L, Balsari A. Caruso A, et al. Among authors: morelli d. Eur J Immunol. 1998 Nov;28(11):3630-8. doi: 10.1002/(SICI)1521-4141(199811)28:11<3630::AID-IMMU3630>3.0.CO;2-6. Eur J Immunol. 1998. PMID: 9842905 Free article.

2

Increase in the therapeutic effect of doxorubicin induced by monoclonal antibodies raised against this drug.

Villa E, Balsari A, Sardini A, Morelli D, Ménard S, Colnaghi MI. Villa E, et al. Among authors: morelli d. Pharmacol Res. 1992 Sep;26 Suppl 2:141-3. doi: 10.1016/1043-6618(92)90636-p. Pharmacol Res. 1992. PMID: 1409283 No abstract available.

3

An anti-doxorubicin monoclonal antibody modulates kinetic and dynamic characteristics of the drug.

Sardini A, Villa E, Morelli D, Ghione M, Ménard S, Colnaghi MI, Balsari A. Sardini A, et al. Among authors: morelli d. Int J Cancer. 1992 Feb 20;50(4):617-20. doi: 10.1002/ijc.2910500422. Int J Cancer. 1992. PMID: 1537626

4

A new monoclonal antibody recognizing anthracyclinic molecule.

Balsari A, Morelli D, Menard S, Tagliabue E, Colnaghi MI, Ghione M. Balsari A, et al. Among authors: morelli d. Anticancer Res. 1990 Jan-Feb;10(1):129-32. Anticancer Res. 1990. PMID: 1692196

5

Monoclonal antibodies against doxorubicin.

Balsari A, Alzani R, Parrello D, Morelli D, Tagliabue E, Gianni L, Isetta AM, Menard S, Colnaghi MI, Ghione M. Balsari A, et al. Among authors: morelli d. Int J Cancer. 1988 Nov 15;42(5):798-802. doi: 10.1002/ijc.2910420528. Int J Cancer. 1988. PMID: 3182109

6

The differential response to interferon gamma by normal and transformed endothelial cells.

Maier JA, Morelli D, Balsari A. Maier JA, et al. Among authors: morelli d. Biochem Biophys Res Commun. 1995 Sep 14;214(2):582-8. doi: 10.1006/bbrc.1995.2325. Biochem Biophys Res Commun. 1995. PMID: 7677768

7

Effect of a bifunctional monoclonal antibody directed against a tumor marker and doxorubicin on the growth of epidermoid vulvar carcinoma grafted in athymic mice.

Morelli D, Ménard S, Pozzi B, Balsari A, Colnaghi MI. Morelli D, et al. Cell Biophys. 1994;24-25:119-26. doi: 10.1007/BF02789222. Cell Biophys. 1994. PMID: 7736515

8

Protection against doxorubicin-induced alopecia in rats by liposome-entrapped monoclonal antibodies.

Balsari AL, Morelli D, Ménard S, Veronesi U, Colnaghi MI. Balsari AL, et al. Among authors: morelli d. FASEB J. 1994 Feb;8(2):226-30. doi: 10.1096/fasebj.8.2.8119493. FASEB J. 1994. PMID: 8119493

9

Modulation of drug-induced cytotoxicity by a bispecific monoclonal antibody that recognizes the epidermal growth factor receptor and doxorubicin.

Morelli D, Sardini A, Villa E, Villa ML, Ménard S, Colnaghi MI, Balsari A. Morelli D, et al. Cancer Immunol Immunother. 1994 Mar;38(3):171-7. doi: 10.1007/BF01525638. Cancer Immunol Immunother. 1994. PMID: 8124685 Free PMC article.

10

Relevance of antibody valency in EGF receptor modulation.

Morelli D, Villa E, Tagliabue E, Perletti L, Villa ML, Ménard S, Balsari A, Colnaghi MI. Morelli D, et al. Scand J Immunol. 1994 May;39(5):453-8. doi: 10.1111/j.1365-3083.1994.tb03400.x. Scand J Immunol. 1994. PMID: 8191221

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

273 results

Search Page

Filters